SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BNFT, ATCO, ABMD, AVEO
NEW YORK, Nov. 03, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Benefitfocus, Inc. (NASDAQ: BNFT)’s sale to Voya Financial, Inc. for $10.50 per share. If you are a Benefitfocus shareholder, click here to learn more about your rights and options.
Atlas Corp. (NYSE: ATCO)’s sale to Poseidon Acquisition Corp. for $15.50 per share in cash. If you are an Atlas shareholder, click here to learn more about your rights and options.
ABIOMED, Inc. (NASDAQ: ABMD)’s sale to Johnson & Johnson. Under the terms of the agreement, ABIOMED shareholders would receive $380.00 per share in cash and a non-tradeable contingent value right entitling the holder to receive up to $35.00 per share in cash if certain commercial and clinical milestones are achieved. If you are an ABIOMED shareholder, click here to learn more about your rights and options.
AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)’s sale to LG Chem, Ltd. for $15.00 per share. If you are an AVEO shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
